What You Should Know:

您应该知道：

–              Finnish health tech company Medixine has strengthened its presence in the U.S. market, announcing a deepened technological partnership with Nonin Medical, a leading manufacturer of wearable and noninvasive medical monitoring devices.

–芬兰健康技术公司Medixine加强了其在美国市场的影响力，宣布与领先的可穿戴和无创医疗监测设备制造商Nonin Medical建立了深化的技术合作伙伴关系。

–              With the U.S. market for remote patient monitoring expected to exceed USD 25 billion by 2028, the collaboration is an important milestone in Medixine’s continued U.S. growth.

–到2028年，美国远程患者监测市场预计将超过250亿美元，此次合作是Medixine在美国持续增长的重要里程碑。

Driving Healthcare Innovation: Integrating Remote Patient Monitoring and Device Technology

推动医疗创新：整合远程患者监测和设备技术

An aging population and cost pressures are driving digitalization in healthcare. Remote patient monitoring is increasingly used for chronic diseases, which constitute 86% of healthcare costs in the US and globally. This trend is expected to continue.

人口老龄化和成本压力正在推动医疗保健数字化。远程患者监测越来越多地用于慢性病，慢性病占美国和全球医疗保健费用的86%。预计这一趋势将继续下去。

A new partnership merges Medixine’s remote patient monitoring software with Nonin’s pulse oximetry devices, aiming to enhance patient care and reduce clinician burden. The collaboration focuses on overnight oximetry for pre-screening patients for supplemental oxygen and potential sleep disorders like obstructive sleep apnea..

新的合作伙伴关系将Medixine的远程患者监测软件与Nonin的脉搏血氧仪设备合并，旨在加强患者护理并减轻临床医生负担。该合作的重点是夜间血氧饱和度测定，用于预先筛查患者的补充氧气和潜在的睡眠障碍，如阻塞性睡眠呼吸暂停。。